2m 2m 2m 2m 2m 2m 2m
Vireo Growth (VREOF)
OTC
$8.51-$0.40 (-4.49%)
Price as of Oct 22, 2026- $438.6MMarket Cap
- -54.97%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Vireo Growth (VREOF)
$8.51-$0.40 (-4.49%)
VREOF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.51 | ||
Change | -$0.40 (-4.49%) | ||
Open | $8.97 | ||
High | $9.01 | ||
Low | $8.36 | ||
Previous Close | $8.91 | ||
Volume | 19,134 | ||
30-Day Average Volume | 41,016 | ||
1-Week Change | -7.10% | ||
1-Month Change | -29.08% | ||
1-Year Change | -54.97% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 51.5M | ||
Total Assets | $1.3B | ||
Market Cap | $438.6M | ||
Enterprise Value | $657.9M | ||
Period: QTR TTM FY | |||
Revenue | $209.3M | ||
Net Income | -$100,000.00 | ||
Free Cash Flow | -$105.8M | ||
EBIT | $21.8M | ||
EBITDA | $26.2M | ||
Net Working Capital | $3.8M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 25 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 1 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | 183 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 06/05/2026 | ||
Earnings & Revenue